MEDAREX INC
10-C, 1996-05-22
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MEDAREX INC, SC 13E4/A, 1996-05-22
Next: MEDAREX INC, 10-C, 1996-05-22



<PAGE>
 
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   FORM 10-C
                REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
                          INTERDEALER QUOTATION SYSTEM
                  FILED PURSUANT TO SECTION 13 OR 15(d) OF THE
                SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17
                              OR 15d-17 THEREUNDER
                                 MEDAREX, INC.
            -------------------------------------------------------
                 (Exact name of issuer as specified in charter)

                1545 Route 22 East, Annandale, New Jersey 08801
            -------------------------------------------------------
                    (Address of principal executive offices)

Issuer's telephone number, including area code  (908) 713-6001
                                               --------------------

                   I.  CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of shares
outstanding:

1.  Title of security                                   Redeemable Warrants
2.  Number of shares outstanding before the change      4,003,411
3.  Number of shares outstanding after the change       121,389
4.  Effective date of change                            May 15, 1996
5.  Method of change:

   Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)

        Conversion into Common Stock upon exercise of Redeemable Warrants
      ---------------------------------------------------------------------

   Give brief description of transaction  Exercise of 3,882,022 Redeemable
                                        ----------------------------------
Warrants for 4,534,202 shares of Common Stock pursuant to Warrant Reduction
- ---------------------------------------------------------------------------
Offer
- -------------------------------------------------------

                          II. CHANGE IN NAME OF ISSUER

1. Name prior to change____________________________________________________

2. Name after change_______________________________________________________

3. Effective date of charter amendment changing name_______________________

4. Date of shareholder approval of change, if required_____________________

Date May 22, 1996                  /s/ Michael A. Appelbaum
    --------------------------     -----------------------------
                                   Michael A. Appelbaum - Senior Vice
                                   President - Finance and Administration
                                   (Principal Financial and Accounting Officer)


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission